MedTrace Logo

Metabolic Effects of a Thermogenic Ready-to-drink Beverage

NCT05194475 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2022-08-09

No results posted yet for this study

Summary

This study is a randomized, double-blind, placebo-controlled crossover trial examining the metabolic effects of a novel ready-to-drink (RTD) beverage. Healthy adult males and females will be recruited for participation. Each participant will complete two conditions in random order: 1) RTD thermogenic beverage ; and 2) placebo (consisting of the flavoring of the thermogenic beverage without the active ingredients). In each condition, metabolism (resting metabolic rate), hemodynamic (heart rate and blood pressure), and subjective (ratings of energy, focus, concentration, alertness, and mood) assessments will be completed at baseline, 30 minutes after beverage consumption, and 30 minutes after the second round of assessments.

Conditions

  • Metabolic Rate
  • Metabolism

Interventions

OTHER

Thermogenic Ready-to-drink Beverage

Thermogenic ready-to-drink beverage, which will be ingested by the participant.

OTHER

Placebo Ready-to-drink Beverage

Placebo ready-to-drink beverage, which will be ingested by the participant.

Sponsors & Collaborators

  • EHP Labs

    collaborator UNKNOWN

  • Texas Tech University

    lead OTHER

Principal Investigators

  • Grant M Tinsley, PhD · Texas Tech University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-18
Primary Completion
2022-05-06
Completion
2022-05-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05194475 on ClinicalTrials.gov